Science & Research

Science & Research

Summary

In collaboration with industry and the public, FDA creates an annual list of regulatory science initiatives on generic drugs.

Original reporting

Open original source

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage